A Pharmacokinetic and Safety Study of TAK-925 in Participants With Idiopathic Hypersomnia

Condition:   Idiopathic Hypersomnia Interventions:   Drug: TAK-925;   Drug: TAK-925 Placebo Sponsor:   Millennium Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials